m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma

m6A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma

BackgroundThis study aims to establish an N6-methyladenosine (m6A) RNA methylation regulators-mediated methylation model and explore its role in predicting prognostic accuracy of immune contexture and characterizations of clear cell renal cell carcinoma (ccRCC).MethodsThe m6A modification subclasses...

Full description

Bibliographic Details
Main Authors: Wenhao Xu, Xi Tian, Wangrui Liu, Aihetaimujiang Anwaier, Jiaqi Su, Wenkai Zhu, Fangning Wan, Guohai Shi, Gaomeng Wei, Yuanyuan Qu, Hailiang Zhang, Dingwei Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
clear cell renal cell carcinoma
tumor microenvironment
N6-methyladenosine
m6A modification subclasses
immunotherapies
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.709579/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.709579/full

Similar Items